Beyond the Prescription: How GLP-1 Companion Digital Programs Address Persistence to Medication and Postcessation Weight Regain
Source: Image created by JMIR Publications/Authors; Copyright: JMIR Publications; License: Creative Commons Attribution (CC-BY) New paper highlights the need for integrated digital behavioral support, proposing a “habit window hypothesis” and associated research agenda to maximize the long-term success of GLP-1 therapies. (Toronto, September 9, 2026) Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant hurdles for many patients. A new viewpoint paper published in the Journal of Medical Internet Research highlights a fundamental challenge: medication alone is not enough to secure long-term behavioral change. In the paper titled “Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint onRead More →










